Tevogen Bio Holdings (STU:G28) Total Long-Term Liabilities : €2.84 Mil (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Tevogen Bio Holdings Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Tevogen Bio Holdings's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was €2.84 Mil.

Tevogen Bio Holdings Total Long-Term Liabilities Historical Data

The historical data trend for Tevogen Bio Holdings's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tevogen Bio Holdings Total Long-Term Liabilities Chart

Tevogen Bio Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Total Long-Term Liabilities

20.78

13.89

13.25

1.04

Tevogen Bio Holdings Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Long-Term Liabilities	Get a 7-Day Free Trial						0.21	0.31	0.06	1.04	2.84

Tevogen Bio Holdings Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Tevogen Bio Holdings Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Tevogen Bio Holdings's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Tevogen Bio Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (STU:G28) » Definitions » Total Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

TVGN:USA

Address

15 Independence Boulevard, Warren, NJ, USA, 07059

Website

https://www.tevogen.com

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Tevogen Bio Holdings Headlines

No Headlines